BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7876544)

  • 1. Role of ETS1 in IL-2 gene expression.
    Romano-Spica V; Georgiou P; Suzuki H; Papas TS; Bhat NK
    J Immunol; 1995 Mar; 154(6):2724-32. PubMed ID: 7876544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ETS1, NFkappaB and AP1 synergistically transactivate the human GM-CSF promoter.
    Thomas RS; Tymms MJ; McKinlay LH; Shannon MF; Seth A; Kola I
    Oncogene; 1997 Jun; 14(23):2845-55. PubMed ID: 9190901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ETS1 transactivates the human GM-CSF promoter in Jurkat T cells stimulated with PMA and ionomycin.
    Thomas RS; Tymms MJ; Seth A; Shannon MF; Kola I
    Oncogene; 1995 Nov; 11(10):2135-43. PubMed ID: 7478534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the human stress response gene GADD153 expression: role of ETS1 and FLI-1 gene products.
    Seth A; Giunta S; Franceschil C; Kola I; Venanzoni MC
    Cell Death Differ; 1999 Sep; 6(9):902-7. PubMed ID: 10510472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A role for Ets1, synergizing with AP-1 and GATA-3 in the regulation of IL-5 transcription in mouse Th2 lymphocytes.
    Wang J; Shannon MF; Young IG
    Int Immunol; 2006 Feb; 18(2):313-23. PubMed ID: 16373364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ETS1 and ETS2 in p53 regulation: spatial separation of ETS binding sites (EBS) modulate protein: DNA interaction.
    Venanzoni MC; Robinson LR; Hodge DR; Kola I; Seth A
    Oncogene; 1996 Mar; 12(6):1199-1204. PubMed ID: 8649821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophilic inflammation: mechanisms regulating IL-5 transcription in human T lymphocytes.
    Wang J; Young IG
    Allergy; 2007 Oct; 62(10):1131-8. PubMed ID: 17845581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PEA3, Oct 1 and Oct 2 positively regulate the human ETS1 promoter.
    Chen JH; Wright CD
    Oncogene; 1993 Dec; 8(12):3375-83. PubMed ID: 8247540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transactivation of GATA-1 promoter with ETS1, ETS2 and ERGB/Hu-FLI-1 proteins: stabilization of the ETS1 protein binding on GATA-1 promoter sequences by monoclonal antibody.
    Seth A; Robinson L; Thompson DM; Watson DK; Papas TS
    Oncogene; 1993 Jul; 8(7):1783-90. PubMed ID: 8510925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcriptional regulation of osteopontin gene in vivo by PEBP2alphaA/CBFA1 and ETS1 in the skeletal tissues.
    Sato M; Morii E; Komori T; Kawahata H; Sugimoto M; Terai K; Shimizu H; Yasui T; Ogihara H; Yasui N; Ochi T; Kitamura Y; Ito Y; Nomura S
    Oncogene; 1998 Sep; 17(12):1517-25. PubMed ID: 9794229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ETS1 lowers capillary endothelial cell density at confluence and induces the expression of VE-cadherin.
    Lelièvre E; Mattot V; Huber P; Vandenbunder B; Soncin F
    Oncogene; 2000 May; 19(20):2438-46. PubMed ID: 10828886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of the human poly(ADP-ribose) polymerase promoter by the ETS transcription factor.
    Soldatenkov VA; Albor A; Patel BK; Dreszer R; Dritschilo A; Notario V
    Oncogene; 1999 Jul; 18(27):3954-62. PubMed ID: 10435618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the transcription factor c-ets1 take part in the regulation of angiogenesis and tumor invasion?
    Vandenbunder B; Wernert N; Queva C; Desbiens X; Stehelin D
    Folia Biol (Praha); 1994; 40(5):301-13. PubMed ID: 7534726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
    Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Negative regulatory elements in the human ETS1 gene promoter.
    Chen JH; Jeha S; Oka T
    Oncogene; 1993 Jan; 8(1):133-9. PubMed ID: 8423991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of interleukin 2 gene expression: discrepancy between enhancer activity and endogenous gene expression.
    Mårtensson IL; Leanderson T
    Eur J Immunol; 1989 Jan; 19(1):145-9. PubMed ID: 2537733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-2 and long-term T cell activation induce physical and functional interaction between STAT5 and ETS transcription factors in human T cells.
    Rameil P; Lécine P; Ghysdael J; Gouilleux F; Kahn-Perlès B; Imbert J
    Oncogene; 2000 Apr; 19(17):2086-97. PubMed ID: 10815800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides.
    Chen Z; Fisher RJ; Riggs CW; Rhim JS; Lautenberger JA
    Cancer Res; 1997 May; 57(10):2013-9. PubMed ID: 9157999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ets up-regulates MET transcription.
    Gambarotta G; Boccaccio C; Giordano S; Andŏ M; Stella MC; Comoglio PM
    Oncogene; 1996 Nov; 13(9):1911-7. PubMed ID: 8934537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.